Skip to main content
Journal cover image

The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521

Publication ,  Conference
Hall, WA; Karrison, TG; Rosenthal, SA; Amin, M; Gomella, LG; Purdy, JA; Sartor, O; Michalski, JM; Garzotto, M; Bergom, C; Jani, A; Lawton, CAF ...
Published in: International Journal of Radiation Oncology*Biology*Physics
November 2018

Duke Scholars

Published In

International Journal of Radiation Oncology*Biology*Physics

DOI

ISSN

0360-3016

Publication Date

November 2018

Volume

102

Issue

3

Start / End Page

S13 / S14

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 5105 Medical and biological physics
  • 3407 Theoretical and computational chemistry
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0299 Other Physical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hall, W. A., Karrison, T. G., Rosenthal, S. A., Amin, M., Gomella, L. G., Purdy, J. A., … Feng, F. Y. (2018). The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521. In International Journal of Radiation Oncology*Biology*Physics (Vol. 102, pp. S13–S14). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2018.06.125
Hall, W. A., T. G. Karrison, S. A. Rosenthal, M. Amin, L. G. Gomella, J. A. Purdy, O. Sartor, et al. “The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521.” In International Journal of Radiation Oncology*Biology*Physics, 102:S13–14. Elsevier BV, 2018. https://doi.org/10.1016/j.ijrobp.2018.06.125.
Hall WA, Karrison TG, Rosenthal SA, Amin M, Gomella LG, Purdy JA, et al. The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2018. p. S13–4.
Hall, W. A., et al. “The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521.” International Journal of Radiation Oncology*Biology*Physics, vol. 102, no. 3, Elsevier BV, 2018, pp. S13–14. Crossref, doi:10.1016/j.ijrobp.2018.06.125.
Hall WA, Karrison TG, Rosenthal SA, Amin M, Gomella LG, Purdy JA, Sartor O, Michalski JM, Garzotto M, Bergom C, Jani A, Lawton CAF, Simko J, Moore J, Gore EM, Lee WR, Nguyen PL, Danielson B, Sandler HM, Feng FY. The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2018. p. S13–S14.
Journal cover image

Published In

International Journal of Radiation Oncology*Biology*Physics

DOI

ISSN

0360-3016

Publication Date

November 2018

Volume

102

Issue

3

Start / End Page

S13 / S14

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 5105 Medical and biological physics
  • 3407 Theoretical and computational chemistry
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0299 Other Physical Sciences